Harm Tiddens
Chief Medical Officer Thirona Bio
Seminars
Tuesday 15th September 2026
AI-Based Mucus Analysis: From Automated Quantification at Scale to Multidimensional Patient Phenotyping, Treatment Response & Disease Progression Monitoring
2:00 pm
- How does fully automated AI enable reproducible mucus plug assessment across large cohorts, and what does validation in real-world COPD and other lung disease data tell us about its robustness?
- How can mucus analysis, combined with complementary structural CT metrics, better characterize COPD heterogeneity and patient phenotypes?
- How can sensitive quantitative CT measurements detect subtle changes over time to assess early treatment response and advance disease progression prediction?
